U.S. Markets close in 1 hr 26 mins

Invictus MD Strategies Corp. (IVITF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0084+0.0004 (+4.87%)
As of 12:41PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0080
Open0.0071
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0071 - 0.0100
52 Week Range0.0010 - 0.1840
Volume48,698
Avg. Volume108,546
Market Cap1.045M
Beta (5Y Monthly)5.11
PE Ratio (TTM)N/A
EPS (TTM)-0.1410
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 17, 2016
1y Target EstN/A
  • CNW Group

    Invictus Announces Signing of a Purchase Agreement

    VANCOUVER, BC , June 22, 2020 /CNW/ - Invictus MD Strategies Corp. (GENE-H.V) (the "Company") announced today that it has entered into an investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage"). The purchaser is Acreage Developments Corp. (the "Investor"), a privately-owned company that is unrelated to the Company and its directors and officers. Completion of the sale is subject to condition precedents including Court approval of the transaction and a plan of compromise and arrangement (the "Plan") being approved by the creditors of Acreage and the Court in the CCAA proceedings currently underway involving the Company and its subsidiaries.

  • CNW Group

    Invictus MD Strategies Corp. - Change of Management

    The Company wishes to thank Ms. Toor for her service. The Company's Controller, Ms. Elena Gershtein has been appointed Acting CFO. Elena has a Bachelor of Commerce Degree in Accountancy from the University of British Columbia .

  • CNW Group

    Invictus Announces Director Resignation

    Invictus Announces Director Resignation